Polygiene AB (publ.) Share Price Nasdaq Stockholm
Equities
SE0007692157
Specialty Chemicals
Sales 2024 * | 145M 13.41M 1.12B | Sales 2025 * | 161M 14.89M 1.24B | Capitalization | 314M 29.05M 2.42B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.85 x |
Net cash position 2024 * | 46M 4.25M 355M | Net cash position 2025 * | 57M 5.27M 439M | EV / Sales 2025 * | 1.6 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
19.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.11% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrika Bjork
CEO | Chief Executive Officer | 56 | 10/17/10 |
Niklas Blomstedt
DFI | Director of Finance/CFO | - | 15/22/15 |
Sue Bethel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 01/19/01 | |
Director/Board Member | 71 | 11/23/11 | |
Daniel Röme
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/18/01 |
1st Jan change | Capi. | |
---|---|---|
+14.70% | 64.83B | |
-1.61% | 46.29B | |
+14.58% | 40.05B | |
+20.84% | 26.72B | |
+1.16% | 17.45B | |
-21.87% | 15.82B | |
+1.11% | 15.02B | |
-11.34% | 14.73B | |
-20.82% | 13.34B |